Riskpilot← Back to searchSign inGet full accessNTR ApS
APSActiveCVR 41551070Færøvej 12Hospital activities · NACE 8610Est. 20204 employeeswww.ntrconsulting.dk
Revenue 2025
DKK 3,6M
-38% vs 2024
EBITDA margin
43.2%
-33% vs 2024
Equity ratio
84.5%
Financial strength
Net profit 2025
DKK 1,2M
-34% vs 2024
| Revenue | DKK 3,6M | -38% |
| EBITDA | DKK 1,6M | -33% |
| Net profit | DKK 1,2M | -34% |
| Total assets | DKK 1,7M | -30% |
| Equity | DKK 1,4M | -30% |
| Employees | 4 | — |
Legal name
NTR ApS
CVR number
41551070
Legal form
Anpartsselskab
NACE code
8610 · Hospital activities
Founded
28. juli 2020
Share capital
DKK 80.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive radiologisk virksomhed samt hermed forbundet virksomhed.
Address
Færøvej 12
Phone
+4526794117
Email
Info@nordicteleradiology.dk
Website
www.ntrconsulting.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.694 | 5.071 | 6.614 | 5.833 | 3.593 |
| Staff expenses | -1.679 | -3.220 | -4.558 | -3.511 | -2.042 |
| EBITDA | 1.015 | 1.851 | 2.056 | 2.322 | 1.551 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1.015 | 1.851 | 2.056 | 2.322 | 1.551 |
| Net financials | -4 | -18 | -23 | -6 | -7 |
| Profit before tax | 1.011 | 1.833 | 2.033 | 2.316 | 1.544 |
| Tax | 241 | 415 | 456 | 511 | 353 |
| Net profit | 770 | 1.417 | 1.577 | 1.805 | 1.191 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1.558 | 1.806 | 2.588 | 2.443 | 1.702 |
| Equity | 850 | 917 | 1.744 | 2.049 | 1.439 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 708 | 889 | 844 | 395 | 263 |
| Total debt | 708 | 889 | 844 | 395 | 263 |
EBITDA margin
43.2%
This company
15.8%
Market median
+173% vs market
20212025
Equity ratio
84.5%
This company
38.2%
Market median
+121% vs market
20212025
Return on equity
82.7%
This company
18.4%
Market median
+349% vs market
20212025
Net profit margin
33.1%
This company
8.1%
Market median
+309% vs market
20212025
Asset turnover
2.11×
This company
1.12×
Market median
+88% vs market
20212025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-07-28 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RG Management | Management | 2020 |
TF Management | Management | 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2022 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2020 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2020 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Diagnostix Holding ApS
NTR ApS Board members of NTR ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robert Gabriel Coumine Riis | Management | 0 companies |
| Thomas Frese Hasseriis | Management | 0 companies |